CollPlant Biotechnologies Ltd (CLGN) › Cash & EquivalentsCollPlant Biotechnologies Ltd (CLGN) — Cash & EquivalentsAnnual figures by fiscal year, from SEC filings.2018: $5.35M2019: $3.79M2020: $3.33M2021: $13.15M2022: $29.65M2023: $26.67M2024: $11.91M2025: $5.59M$5.59M2018Cash & Equivalents (USD)2025Fiscal YearCash & EquivalentsChange YoY2025$5.59M-53.1%2024$11.91M-55.4%2023$26.67M-10.0%2022$29.65M+125.5%2021$13.15M+294.5%2020$3.33M-12.1%2019$3.79M-29.2%2018$5.35M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share